Eurazeo SE — M&A Activity 2016

Mar 21, 2016

PARIS, MARCH 21, 2016

EURAZEO IN EXCLUSIVE DISCUSSIONS TO ACQUIRE NOVACAP GROUP, A LEADING GLOBAL PHARMACEUTICAL AND ESSENTIAL CHEMICALS COMPANY.

Eurazeo has entered into exclusive discussions with Ardian, the majority shareholder of the Novacap Group, with a view to acquire a controlling stake in the company, alongside Mérieux Développement, Ardian and the Novacap management.

Eurazeo, Mérieux Développement and Ardian are looking forward to supporting the Group in the next stage of its development both organically, through innovation and expansion of its international footprint, as well as through acquisitions and strong partnerships.

Novacap is a global group producing and distributing Active Pharmaceutical Ingredients and essential chemicals products that are used in everyday applications such as aspirin, paracetamol, other APIs, ketamine, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents, hydrochloric acid and ferric chloride.

The Novacap Group enjoys leading positions in its target growing end-markets of pharmaceutical & healthcare, cosmetics & fragrances, food & feed, home care and environment. The Group is an industry leader across a wide range of products (e.g. No.1 in aspirin and salicylic acid globally, No.2 in paracetamol and sodium bicarbonate in Europe). The Novacap Group benefits from a solid European platform complemented by a well-established presence in Asia and an increasing footprint in the USA. With more than 750 customers across more than 80 countries, Novacap generated revenues approximately of €600 million in 2015.

Novacap is headquartered in Lyon (France). It employs c.1,600 people across 14 facilities worldwide and has a global commercial network.

***

About Eurazeo

With a diversified portfolio of 5 billion euros in assets, Eurazeo is one of the leading listed investment companies in Europe. Its purpose and mission is to identify, accelerate and enhance the transformation potential of the companies in which it invests. The Company covers most private equity segments through its four business divisions – Eurazeo Capital, Eurazeo Croissance, Eurazeo PME and Eurazeo Patrimoine. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo is notably either a majority or key shareholder in AccorHotels, ANF Immobilier, Asmodee, Desigual, Elis, Europcar, Fintrax, Foncia, InVivo NSA, Moncler, and smaller companies, including the investments of Eurazeo PME and Eurazeo Croissance. Eurazeo is listed on Euronext Paris.

ISIN: FR0000121121 - Bloomberg: RF FP - Reuters: EURA.PA

About Mérieux Développement

Mérieux Développement is an affiliate of Institut Mérieux, which employs around 15,000 employees worldwide, with consolidated revenues exceeding 2.4 billion Euros in 2015. Mérieux Développement is an evergreen fund specialized in the healthcare and nutrition sectors, conducting private equity and venture capital transactions on a global basis. Mérieux Développement brings its expertise and international network to enable entrepreneurs to disrupt and create new markets.

About Ardian

Ardian, founded in 1996 and led by Dominique Senequier, is an independent private investment company with assets of US\$55bn managed or advised in Europe, North America and Asia. The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors while fueling growth in economies across the world. Ardian's investment process embodies three values: excellence, loyalty and entrepreneurship. Ardian maintains a truly global network, with more than 410 employees working through twelve offices in Paris, London, Frankfurt, Milan, Madrid, Zurich, New York, San Francisco, Beijing, Singapore, Jersey, Luxembourg. The company offers its 470 investors a diversified choice of funds covering the full range of asset classes, with Ardian Fund of Funds (primary, early secondary and secondary), Ardian Private Debt, Direct Funds (including Ardian Mid Cap Buyout, Ardian Expansion, Ardian Growth and Ardian Co-Investment), Ardian Infrastructure, Ardian Real Estate and made to measure mandates with Ardian Mandates.

Eurazeo financial timetable	May 12, 2016	General Shareholders' Meeting Q1 2016 revenue
	July 27, 2016	H1 2016 results
	November 10, 2016	Q3 2016 revenue

COMPANY CONTACTS PRESS CONTACT

CAROLINE COHEN DIRECTOR INVESTOR RELATIONS Mail: ccohen@eurazeo.com Tel: +33 (0)1 44 15 16 76

SANDRA CADIOU DIRECTOR OF COMMUNICATIONS Mail: scadiou@eurazeo.com Tel: +33 (0)1 44 15 80 26

HAVAS WORLDWIDE PARIS MARIE FROCRAIN Mail: marie.frocrain@havasww.com Tel: +33 (0)1 58 47 86 64 +33 (0) 6 04 67 49 75